論文

査読有り 国際誌
2021年6月7日

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.

Scientific reports
  • Daichi Maeda
  • Nobuyuki Kagiyama
  • Kentaro Jujo
  • Kazuya Saito
  • Kentaro Kamiya
  • Hiroshi Saito
  • Yuki Ogasahara
  • Emi Maekawa
  • Masaaki Konishi
  • Takeshi Kitai
  • Kentaro Iwata
  • Hiroshi Wada
  • Masaru Hiki
  • Taishi Dotare
  • Tsutomu Sunayama
  • Takatoshi Kasai
  • Hirofumi Nagamatsu
  • Tetsuya Ozawa
  • Katsuya Izawa
  • Shuhei Yamamoto
  • Naoki Aizawa
  • Ryusuke Yonezawa
  • Kazuhiro Oka
  • Shin-Ichi Momomura
  • Yuya Matsue
  • 全て表示

11
1
開始ページ
11957
終了ページ
11957
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s41598-021-91368-z

Frailty is a common comorbidity associated with adverse events in patients with heart failure, and early recognition is key to improving its management. We hypothesized that the AST to ALT ratio (AAR) could be a marker of frailty in patients with heart failure. Data from the FRAGILE-HF study were analyzed. A total of 1327 patients aged ≥ 65 years hospitalized with heart failure were categorized into three groups based on their AAR at discharge: low AAR (AAR < 1.16, n = 434); middle AAR (1.16 ≤ AAR < 1.70, n = 487); high AAR (AAR ≥ 1.70, n = 406). The primary endpoint was one-year mortality. The association between AAR and physical function was also assessed. High AAR was associated with lower short physical performance battery and shorter 6-min walk distance, and these associations were independent of age and sex. Logistic regression analysis revealed that high AAR was an independent marker of physical frailty after adjustment for age, sex and body mass index. During follow-up, all-cause death occurred in 161 patients. After adjusting for confounding factors, high AAR was associated with all-cause death (low AAR vs. high AAR, hazard ratio: 1.57, 95% confidence interval, 1.02-2.42; P = 0.040). In conclusion, AAR is a marker of frailty and prognostic for all-cause mortality in older patients with heart failure.

リンク情報
DOI
https://doi.org/10.1038/s41598-021-91368-z
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34099767
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184951
ID情報
  • DOI : 10.1038/s41598-021-91368-z
  • PubMed ID : 34099767
  • PubMed Central 記事ID : PMC8184951

エクスポート
BibTeX RIS